arrow_back Civic Audit
Share share

Lower Drug Prices: Global Benchmarking and Personal Importation

This bill aims to reduce prescription drug prices in the U.S. by aligning them with international benchmarks. It also facilitates individual importation of drugs, potentially saving patients money. Authorities will also target anti-competitive practices by drug manufacturers.
Key points
U.S. drug prices are to be compared with those in other developed countries to potentially lower costs for patients.
Individuals may be able to import cheaper prescription drugs from other developed countries, if deemed safe.
Authorities will take action against drug manufacturers engaging in anti-competitive practices.
article Official text account_balance Process page notifications_active Track this Bill
Status: Introduced
Civic Will
Checking votes...
I support
I oppose
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 119_HR_3493
Sponsor: Rep. Khanna, Ro [D-CA-17]
Process start date: 2025-05-19